Unknown

Dataset Information

0

Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma.


ABSTRACT:

Objectives

Sarcopenia, a novel concept reflecting the degenerative loss of skeletal muscle mass, is an objective indicator of cancer cachexia. We investigated its role as a prognostic biomarker in advanced urothelial carcinoma (UC) patients.

Methods

This retrospective study consisted of 88 UC patients with cT4 and/or metastases to lymph nodes/distant organs. Skeletal muscle index (SMI), an indicator of whole-body muscle mass, was measured from computed tomography (CT) images at the diagnosis. Sarcopenia was defined as SMIs of <43 cm(2)/m(2) for males with body mass index (BMI) <25 cm(2)/m(2), <53 cm(2)/m(2) for males with BMI ? 25 cm(2)/m(2), and <41 cm(2)/m(2) for females. Predictors of overall survival (OS) were examined using Cox proportional hazard models.

Results

Sixty-seven patients (76%) died during the median follow-up of 13 months. The median OS rate was 13 months. Multivariate analysis revealed that SMI was a significant and independent predictor of shorter OS (hazard ratio (HR) 0.90, P <0.001). In the present cohort, 53 (60%) were diagnosed with sarcopenia. The median OS rates were 11 and 31 months for sarcopenic and non-sarcopenic patients, respectively (P <0.001). On multivariate analysis, sarcopenia was a significant and independent predictor of shorter OS (HR 3.36, P <0.001), along with higher C-reactive protein (CRP) (P = 0.001), upper urinary tract cancer (P = 0.007), higher lactate dehydrogenase (LDH) (P = 0.047), and higher alkaline phosphatase (ALP) (P = 0.048).

Conclusion

Sarcopenia, which is readily evaluated on routine CT scans, is a useful prognostic biomarker of advanced UC. Non-sarcopenic patients can expect long-term survival. Evaluating sarcopenia can be helpful for decision-making processes in the management of advanced UC patients.

SUBMITTER: Fukushima H 

PROVIDER: S-EPMC4303429 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma.

Fukushima Hiroshi H   Yokoyama Minato M   Nakanishi Yasukazu Y   Tobisu Ken-ichi K   Koga Fumitaka F  

PloS one 20150122 1


<h4>Objectives</h4>Sarcopenia, a novel concept reflecting the degenerative loss of skeletal muscle mass, is an objective indicator of cancer cachexia. We investigated its role as a prognostic biomarker in advanced urothelial carcinoma (UC) patients.<h4>Methods</h4>This retrospective study consisted of 88 UC patients with cT4 and/or metastases to lymph nodes/distant organs. Skeletal muscle index (SMI), an indicator of whole-body muscle mass, was measured from computed tomography (CT) images at th  ...[more]

Similar Datasets

| S-EPMC9600715 | biostudies-literature
| S-EPMC8649001 | biostudies-literature
| S-EPMC5466664 | biostudies-literature
| S-EPMC5458237 | biostudies-literature
| S-EPMC9821501 | biostudies-literature
| S-EPMC9899238 | biostudies-literature
| S-EPMC5025874 | biostudies-literature
| S-EPMC7402696 | biostudies-literature
| S-EPMC4009980 | biostudies-other
| S-EPMC8718042 | biostudies-literature